Related Experiment Video

Updated: Feb 4, 2026

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

9.9K

METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells

Guang-Jer Wu1,2

  • 1Department of Bioscience Technology and Center for Biomedical Technology, Chung Yuan Christian University, Chung Li 32023, Taiwan. guangj.wu@gmail.com.

International Journal of Molecular Sciences
|October 3, 2018
PubMed

Insights

METCAM/MUC18, a cell adhesion molecule, was previously thought to predict ovarian carcinoma malignancy. Recent findings reveal it actually suppresses tumor growth and metastasis, offering new therapeutic potential.

Area of Science:

  • Molecular biology
  • Oncology
  • Biochemistry

Background:

  • METCAM/MUC18 is an Ig-like cell adhesion molecule (CAM) involved in cell interactions and signaling.
  • Previous studies suggested METCAM/MUC18 as a biomarker for advanced ovarian carcinoma, potentially promoting malignancy.
  • This association was questioned due to conflicting research findings.

Purpose of the Study:

  • To investigate the actual role of METCAM/MUC18 in ovarian carcinoma development and metastasis.
  • To explore the potential of METCAM/MUC18 as a therapeutic target for ovarian cancer.

Main Methods:

  • Analysis of METCAM/MUC18 expression in ovarian carcinoma.
  • Investigation of METCAM/MUC18's function in tumor cell behavior.
  • Exploration of potential therapeutic applications using recombinant METCAM/MUC18.

Main Results:

  • METCAM/MUC18 acts as a suppressor of tumor growth and metastasis in ovarian carcinoma.
  • The previously observed positive correlation between METCAM/MUC18 and advanced stages was deemed fortuitous.
  • Mechanisms underlying METCAM/MUC18's suppressive role in early tumor development were elucidated.

Conclusions:

  • METCAM/MUC18 functions as a tumor and metastasis suppressor in ovarian carcinoma, contrary to prior hypotheses.
  • Recombinant METCAM/MUC18 proteins show promise as therapeutic agents to reduce ovarian cancer malignancy.
Keywords:
BG-1 cell linesEMTIP injectionsMETCAM/MUC18SC &ampSK-OV-3 &ampascites formationfemale athymic nude micehuman ovarian carcinoma cellsmechanismstumorigenicity

More Related Videos

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells08:17

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells

Published on: December 9, 2016

11.2K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K

Related Concept Videos

Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
299
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
902
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.0K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.9K
Biodiversity and Human Values01:24

Biodiversity and Human Values

Human civilization relies on biodiversity in many ways. Sudden changes in species biodiversity result in environmental changes that can modify weather patterns and therefore human civilizations.
17.1K